SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-325520
Filing Date
2018-11-13
Accepted
2018-11-13 16:22:37
Documents
3
Period of Report
2018-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d654661d8ka.htm 8-K/A 16697
2 EX-10.1 d654661dex101.htm EX-10.1 766529
3 GRAPHIC g654661g1113031340867.jpg GRAPHIC 3773
  Complete submission text file 0001193125-18-325520.txt   789777
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38327 | Film No.: 181178283
SIC: 2834 Pharmaceutical Preparations